Minretumomab structure
|
Common Name | Minretumomab | ||
|---|---|---|---|---|
| CAS Number | 195189-17-4 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of MinretumomabMinretumomab (CC-49) is a mouse anti-TAG-72 (tumor-associated glycoprotein 72) monoclonal antibody and a radioimmunoconjugate. Minretumomab can be used for the research of cancer and radioimmunotherapy (RIT)[1][2]. |
| Name | Minretumomab [inn] |
|---|
| Description | Minretumomab (CC-49) is a mouse anti-TAG-72 (tumor-associated glycoprotein 72) monoclonal antibody and a radioimmunoconjugate. Minretumomab can be used for the research of cancer and radioimmunotherapy (RIT)[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Minretumomab 和吉西他滨联合治疗在小鼠结肠癌模型中显示出抗肿瘤作用[1]。 |
| References |
| No Any Chemical & Physical Properties |